Ian G Rennie

Title: Ian G Rennie: Innovator in Genetic Testing for Diabetic Retinopathy

Introduction

Ian G Rennie is a notable inventor based in Newbold, GB. He has made significant contributions to the field of genetic testing, particularly in relation to diabetic retinopathy. His innovative work focuses on predicting the risk of sight-threatening conditions in diabetic patients.

Latest Patents

Ian G Rennie holds a patent for a method and kit designed to detect genetic predisposition to sight-threatening diabetic retinopathy. This patent involves isolating genomic DNA from a sample taken from a diabetic patient. The genetic polymorphism pattern for the genes IL-1A, IL-1B, and IL-1RN is identified in the DNA. The identified pattern is then compared with control patterns of known polymorphisms. Patients who express a genetic polymorphism pattern associated with an increased risk of sight-threatening diabetic retinopathy are identified through this method. He has 1 patent to his name.

Career Highlights

Ian G Rennie is associated with Interleukin Genetics, Inc., where he applies his expertise in genetic research. His work has the potential to significantly impact the management and prevention of diabetic retinopathy, a serious complication of diabetes.

Collaborations

Ian has collaborated with notable colleagues, including Gordon W Duff and Patrick R S Richardson. Their combined efforts contribute to advancements in genetic testing and patient care.

Conclusion

Ian G Rennie's innovative approach to detecting genetic predisposition to diabetic retinopathy showcases his commitment to improving healthcare outcomes for diabetic patients. His contributions to the field are invaluable and highlight the importance of genetic research in modern medicine.